| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000003340 |
| Receipt No. | R000004050 |
| Official scientific title of the study | Prevalance of the sleep apnea syndrome in cardiac surgery patients |
| Date of disclosure of the study information | 2010/03/16 |
| Last modified on | 2018/03/26 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Prevalance of the sleep apnea syndrome in cardiac surgery patients | |
| Title of the study (Brief title) | Prevalance of the sleep apnea syndrome in cardiac surgery patients | |
| Region |
|
|
| Condition | |||
| Condition | Cardiac surgery patients | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the prevalance of sleep apnea syndrome in cardiac surgery patients, and compare from various data with the severity. |
| Basic objectives2 | Others |
| Basic objectives -Others | prevalance |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The prevalance of sleep apnea syndrome in cardiac surgery patients. |
| Key secondary outcomes | 1)risk factor (Ht, DM, HL, etc)
2)left ventricular function by echocardiography 3)ANP, BNP 4)renin activity, angiotensin-II, aldsterone 5)high sensitivity CRP, oxidative LDL |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients undergoing cardiac surgery
Patients from whom informed consent was obtained |
|||
| Key exclusion criteria | Doctor's decision not to register to this regimen | |||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Akira Sezai |
| Organization | Nihon University school of medicine |
| Division name | Department of Cardiovascular Surgery |
| Address | 30-1 Oyagichi kami-machi, Itabashi-ku, Tokyo |
| TEL | 03-3972-8111 |
| asezai.med@gmail.com | |
| Public contact | |
| Name of contact person | Akira Sezai |
| Organization | Nihon University school of medicine |
| Division name | Department of Cardiovascular Surgery |
| Address | 30-1 Oyagichi kami-machi, Itabashi-ku, Tokyo |
| TEL | 03-3972-8111 |
| Homepage URL | |
| asezai.med@gmail.com | |
| Sponsor | |
| Institute | Sekino Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | I)prevalence of sleep apnea syndrome
II-1)risk factor (Ht, DM, HL, etc) II-2)left ventricular function by echocardiography II-3)ANP, BNP II-4)renin activity, angiotensin-II, aldsterone II-5)high sensitivity CRP, oxidative LD |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004050 |